Perrigo 1st quarter sales up 12%; Menley & James reports 3rd quarter profit.
This article was originally published in The Tan Sheet
Executive Summary
PERRIGO SALES RISE MORE THAN 12% TO $205 MIL. in the company's fiscal 1996 first quarter ended Sept. 30, the Allegan, Mich.-based private-label company reported Oct. 30. Perrigo noted that it is "pleased" with the overall double-digit gain in sales as well as with the initial reception of its new liquid nutritional supplements. The firm began shipping Daily Source liquid nutritional supplements in June
You may also be interested in...
FTC Early Findings In PBM Investigation Coming By Mid-Summer, Chair Kahn Says
The agency is also poised to announce another development in its scrutiny of the drug patents listed in the FDA’s Orange Book.
ImmunityBio Will Aim Anktiva At Large Share Of Bladder Cancer Market
Execs Richard Adcock and Patrick Soon-Shiong told Scrip the company sees an addressable US population of about 20,000 and is aiming for ease of physician adoption.
Scrip M&A Podcast: Which Companies Could Be Acquired Next?
The editorial team from Scrip discusses the M&A potential of various emerging biopharmas, such as Viking, Verona, Altimmune, Xenon and Crinetics.